NEO - NEOGENOMICS INC

10.27
0.180   1.753%

Share volume: 1,432,337
Last Updated: 04-25-2025
Business Services/Services – Research, Development, Testing Labs: -0.08%

PREVIOUS CLOSE
CHG
CHG%
$10.09
0.18
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
15%
Profitability 1%
Dept financing 11%
Liquidity 67%
Performance 17%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
5.33%
1 Month
8.33%
3 Months
-31.72%
6 Months
-23.81%
1 Year
-32.52%
2 Year
-28.18%
Key data
Stock price
$10.27
P/E Ratio 
0.00
DAY RANGE
$9.87 - $10.29
EPS 
-$0.47
52 WEEK RANGE
$8.05 - $19.12
52 WEEK CHANGE
-$32.52
MARKET CAP 
2.115 B
YIELD 
N/A
SHARES OUTSTANDING 
128.158 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
BETA 
1.58
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,426,896
AVERAGE 30 VOLUME 
$1,809,763
Company detail
CEO: Christopher M. Smith
Region: US
Website: neogenomics.com
Employees: 2,100
IPO year: 2004
Issue type: Common Stock
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited.

Recent news
loading